Becton, Dickinson and Company

NYSE:BDX

Medical - Instruments & Supplies

Healthcare
$216.08 +1.67%

+$2.36 today

Market cap
$58.86B
Beta
0.28
P/E (TTM)
35.5
EPS (TTM)
$4.06
Dividend yield
2.60%
52W Low $127.59High $187.35

Volume 1.32M

Average 2.76M

BDX Deferred Tax Liabilities

Taxes owed in future periods because of timing differences between accounting and tax rules.

Becton, Dickinson and CompanyNYSE: BDX

Deferred Tax Liabilities · Q4 FY2026 · quarter ended Sep 2026

Deferred tax liabilities remains negative

Q4 FY2026 deferred tax liabilities was $2.2B, compared with $0 a year earlier. Over 3 fiscal years it compounded at -3.5% a year.

Context

  • Deferred tax liabilities amounted to 4.3% of total assets at the end of Q4 FY2026, up 4.3 pp from a year earlier.
  • Deferred tax liabilities increased in 1 of the last 3 fiscal years.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$2.2B-8.1% QoQ
Last fiscal yearSep 2026
$2.2B— YoY
Year agoSep 2025
$0— since
Deferred Tax Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR-3.5%——
5-year CAGR——
10-year CAGR——

Deferred Tax Liabilities history

USD · from the balance sheet

Latest · FY2026
2.2B USD
Year-over-year change
—
4-year CAGR
-4.8%

Deferred Tax Liabilities vs competitors

How BDX compares with its peers on the latest reported figures

  • BDX's Sep 2026 deferred tax liabilities of $2.2B is the highest of the 11 companies compared; the peer median is $17.31M.
  • Deferred tax liabilities amounts to 4.3% of total assets for BDX, versus a peer median of 0.3%.
BDX Competitors Peer median
Deferred Tax Liabilities for BDX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BDXBecton, Dickinson and CompanySep 2026$2.2B —-3.5%4.3%
MDTMedtronic plcJul 2026$349M -16.1%-20.0%0.4%
SOLVSolventum CorporationJun 2026$157M -32.0%-8.6%1.1%
TFXTeleflex IncorporatedJun 2026$146.14M -60.9%-22.1%2.2%
MMSIMerit Medical Systems, Inc.Sep 2026$37.22M +39.3%+2.1%—
WSTWest Pharmaceutical Services, Inc.Jun 2026$22.4M -2.6%+17.2%0.5%
ICUIICU Medical, Inc.Jun 2026$12.23M -71.7%-33.1%0.3%
BLFSBioLife Solutions, Inc.Mar 2026$198K +52.3%-8.9%0.0%
ABTAbbott LaboratoriesJun 2026$0 —+2.0%0.0%
BAXBaxter International Inc.Jun 2026$0 —-28.2%0.0%
EMBCEmbecta Corp.Mar 2026$0 —+10.7%0.0%
Peer median (excluding BDX) $17.31M-16.1%-8.8%0.3%

Competitors are the stored peer set for BDX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
FY2026
Sep 2026
Cash & Equivalents1.16B1.42B1.86B851M725M
Short-term Investments8M8M445M8M8M
Net Receivables2.19B2.53B3.03B2.99B2.77B
Inventory3.22B3.27B3.84B3.89B3.19B
Other Current Assets1.56B1.45B1.29B1.51B1.62B
Total Current Assets8.14B8.68B10.47B9.26B8.32B
Property, Plant & Equipment (Net)6.01B6.56B6.82B7B6.19B
Goodwill24.62B24.52B26.47B33.02B33.62B
Intangible Assets12.31B10.95B10.92B2.99B0
Long-term Investments00000
Tax Assets00000
Other Non-current Assets1.85B2.08B2.62B3.06B2.66B
Total Non-current Assets44.79B44.1B46.82B46.07B42.47B
Total Assets52.93B52.78B57.29B55.33B50.79B
Account Payables1.7B1.64B1.9B1.97B0
Short-term Debt2.3B1.26B2.31B1.56B944M
Tax Payables157M139M168M00
Deferred Revenue00000
Other Current Liabilities2.49B2.49B3.33B4.45B0
Total Current Liabilities7.81B6.64B8.96B8.31B944M
Long-term Debt14.27B15.15B18.61B17.62B13.42B
Deferred Tax Liabilities2.67B2.45B2.07B02.2B
Deferred Revenue (Non-current)00000
Other Non-current Liabilities2.51B2.33B1.1B4B0
Total Non-current Liabilities19.84B20.34B22.44B21.62B15.62B
Total Liabilities27.65B26.98B31.4B29.94B26.11B
Common Stock365M371M371M371M0
Retained Earnings15.16B15.54B16.14B16.62B0
Accumulated OCI(1.49B)(1.55B)(1.73B)(1.87B)0
Other Stockholders Equity23M24M25M25M50.79B
Minority Interest00000
Total Equity25.28B25.8B25.89B25.39B24.68B
Total Debt16.95B16.82B21.59B19.18B14.37B
Net Debt15.79B15.34B19.73B18.33B13.64B

Becton, Dickinson and Company

NYSE:BDX

Intrinsic Alpha fair value

Locked

Current Price

$216.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.